6,705 press releases indexed under healthcare.
HOUSTON, Aug. 31, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric,...
REYKJAVIK, Iceland, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT80, a proposed interchangeable biosimilar to Entyvio® (vedolizumab) prefilled syringe and autoinjector for subcutaneous administration.
REYKJAVÍK (31. ágúst 2026) – Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hefði tekið til afgreiðslu umsókn um markaðsleyfi í Bandaríkjunum fyrir AVT80, fyrirhugaða hliðstæðu með útskiptileika við Entyivo (vedolizumab) í áfylltri sprautu eða lyfjapenna.
Community Catalyst, the nation's leading health advocacy organization, this morning launched its Vote Like Your Health Depends On It campaign (#VoteLikeHealth) ahead of the midterm elections in November. BOSTON, Aug. 31, 2026 /PRNewswire-PRWeb/ -- Community Catalyst, the nation's leading...
Patient support hubs have quietly become one of the most strategically important — and most contested — functions in pharmaceutical commercialization. For years, the model [read full press release...]
Agreement Resolves all Pending Patent-Related Proceedings Between BioMarin and Ascendis SAN RAFAEL, Calif., Aug. 30, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that it has entered into binding terms with Ascendis Pharma A/S, resolving the patent and...
MUNICH, Aug. 31, 2026 /PRNewswire/ -- The European Society of Cardiology Congress (ESC Congress 2026), one of the world's most influential academic gatherings in cardiovascular medicine, officially kicked off today in Munich, Germany. Huawei showcased its latest innovations in health and...
An AI Consultant in the SpeedyIndex dashboard handled 57% of support requests in its first week. Next up, in Q4 2026: AI agents that rate donor domains by how Google has indexed them over months, quarters and years VANTAA, Finland and HELSINKI, Aug. 30, 2026 /PRNewswire-PRWeb/ --...
Findings build on the established success of the global SAFFRON and China SACHI trials, extending the clinical value of the all-oral combination into the first-line setting Findings build on the established success of the global SAFFRON and China SACHI trials, extending the clinical value of the all-oral combination into the first-line setting
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / August 30, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / August 30, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Sunday 30 August, 2026 Chartered Psychologist/Senior Accredited Psychotherapist Launches Foodsane: A Compassion-Led Alternative to Diet Culture Devon, UK. Dr Joanna North, Chartered Researching Psychologist, Fellow of the British Psychological Society, and Senior Accredited Psychotherapist, has launched Foodsane, a psychology-based wellness community offering a "middle way" between diet culture, weight loss medication and disordered eating. (www.foodsane.co.uk). Drawing on more than forty years of clinical practice, Dr North developed the RAFT framework: Right Amount, Right Food, Right Time and the accompanying concept of Time Related Eating (TRE), both grounded in nervous-system regulation, interoception (body awareness), and self-compassion rather than restriction or willpower. The initi